AKTS Aktis Oncology, Inc.

$23.30▼ -2.67% Healthcare Other
After hours $23.30▲ +0.00% Sep 11, 7:30 PM ET
Volume 228.6K Avg Volume (10D) 274.4K
Key Metrics & Fundamentals
Market Cap
$1.30B
P/E Ratio
–
Div Yield
–%
52W Range
14.72 - 34.19
% vs 50 MA
-7.04%
% vs 200 MA
–%
RSI-14
39.3
MACD Histogram
-0.3100
Beta (1Y vs SPY)
1.71
Free Cash Flow
-$21.85M
Gross Rev
$3.38M
Gross Profit
$3.38M
EBITDA
-$28.02M
COGS
–
Operating Exp
$32.28M
Operating Income
-$28.90M
EBIT
-$28.90M
Pretax Income
-$24.14M
Net Income
-$24.14M
EPS (Diluted)
-0.44
Price & Volume History
Loading chart…
Recent News
Oppenheimer Initiates Coverage on Akoustis Technologies With Outperform Rating, $40 PT
MT Newswires · Sep 9, 2026 12:36 PM
Aktis Oncology to Present at Upcoming September Investor Conferences
GlobeNewswire · Sep 9, 2026 12:00 PM
Aktis Oncology Seen Advancing Targeted Radiation-Based Cancer Drugs, Wedbush Says
MT Newswires · Aug 19, 2026 3:42 PM
Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play
24/7 Wall St. · Aug 19, 2026 12:10 PM
Wedbush Initiates Aktis Oncology at Outperform With $35 Price Target
MT Newswires · Aug 19, 2026 11:22 AM
Aktis: Q2 Earnings Snapshot
Associated Press · Aug 13, 2026 8:19 PM
Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026
GlobeNewswire · Aug 13, 2026 8:01 PM
Aktis Oncology Insider Sold Shares Worth $1,387,558, According to a Recent SEC Filing
MT Newswires · Jul 10, 2026 10:27 AM
Aktis Oncology Insider Sold Shares Worth $1,388,701, According to a Recent SEC Filing
MT Newswires · Jul 10, 2026 10:26 AM
Raymond James Initiates Aktis Oncology at Strong Buy With $40 Price Target
MT Newswires · Jun 16, 2026 9:19 AM
Financial Overview - Income Statement Quarterly

See AKTS's money flow as a full page

Social Sentiment
Avg -0.34 · 7 posts
DDDiscussionTradeCan somebody please analyse the AKTS options, if any?
r/options · Nov 27, 2024
The post argues for a sell recommendation due to excessive debt and a potentially unsustainable situation, indicating a strong negative sentiment.
very_negative -0.80
Lawsuits can kill companies. But when an injunction is not an injunction, it may lead to Resurrection.
r/stocks · Oct 17, 2024
The post highlights a significant legal issue (lawsuits) and a large financial penalty, suggesting a negative outlook for the stock.
negative -0.50
$QCOM long term growth, over 200$. Likely to acquire $AKTS in market share and 6G patent grab. Vanguard mimicking
r/stocks · Sep 16, 2024
The post focuses on AKTS's challenges – bankruptcy, lawsuits, and new board members – indicating a concerning investment outlook.
negative -0.60
DiscussionTrade$QRVO & $QCOM I see them as prime candidates to buy $AKTS, Do I buy all 3? Two Solid stock, one risky but with immense upside?
r/investing · Sep 9, 2024
The poster considers AKTS a promising stock with 'immense upside'.
positive +0.80
Akts an example of high risk and high reward
r/stocks · Aug 24, 2024
The post highlights significant risks like delisting and lawsuits, indicating a bearish sentiment towards the stock.
negative -0.60
Page 1 of 2 (7 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙